Erratum: Changes in symptoms of renal cell carcinoma over four decades (BJU International (2010) 106 (649-653) DOI:10.1111/j.1464-410X.2010.09241.x);Changes in symptoms of renal cell carcinoma over four decades

BJU International

Volumn 106, Issue 5, 2010, Pages 649-653

  Sunela, Kaisa L ^a   Kataja, Matti J ^b   Kellokumpu Lehtinen, Pirkko Liisa I ^a,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

change; incidental findings; RCC; symptoms

Indexed keywords

CREATININE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROCYTOSIS; FATIGUE; FEMALE; FEVER; FLANK PAIN; GENDER; HAND EDEMA; HEMATURIA; HUMAN; HYPERCALCEMIA; HYPERTENSION; INCIDENCE; INCIDENTAL FINDING; KIDNEY CARCINOMA; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGIC FRACTURE; POLLAKISURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; PYELONEPHRITIS; SCHOOL CHILD; SYMPTOMATOLOGY; THROMBOEMBOLISM; UROSEPSIS; VARICOCELE; WEIGHT REDUCTION;

EID: 77955908512     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12546     Document Type: Erratum

References (28)

1. Dayal HH, Wilkinson GS. Epidemiology of renal cell cancer. Semin Urol 1989 7 : 139 43
2. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 1971 28 : 1165 77
3. Sigalow DA, Waldbaum RS, Lowe FC. Identification of asymptomatic renal cell carcinomas utilizing modern radiographic techiques. NY State J Med 1991 91 : 200 2
4. Jubelirer SJ, Rubin M. The use of modern radiologic methods in identifying incidental renal cell carcinoma. WV Med J 1993 89 : 21 3
5. Schips L, Lipsky K, Zigeuner R et al. Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology 2003 62 : 1024 8
6. Gudbjartsson T, Thoroddsen A, Petursdottir V, Hardarson S, Magnusson J, Einarsson GV. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology 2005 66 : 1186 91
7. Bretheau D, Lechevallier E, Eghazarian C, Grisoni V, Coulange C. Prognostic significance of incidental renal cell carcinoma. Eur Urol 1995 27 : 319 23
8. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma - age and stage characterization and clinical implications. Study of 1092 patients (1982-1997). Urology 2000 56 : 58 62
9. Citterio G, Bertuzzi A, Tresoldi M et al. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients. Eur Urol 1997 31 : 286 91
10. Pagano S, Franzoso F, Ruggeri P. Renal cell carcinoma metastases. Review of unusual clinical metastases, metastatic nodes and patterns and comparison between clinical and autopsy metastatic series. Scan J Urol Nephrol 1996 30 : 165 72
11. Wahner-Roedler DL, Sebo TJ. Renal cell carcinoma. Diagnoses based on metastatic manifestations. Mayo Clin Proc 1997 72 : 935 41
12. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003 30 : 843 52
13. Saitoh H. Distant metastasis of renal adenocarcinoma in patients with a tumor thrombus in the renal vein andor vena cava. J Urol 1982 127 : 652 3
14. Ou YC, Yang CR, Ho HC et al. The symptoms of renal cell carcinoma related to patients' survival. J Chin Med Assoc 2003 66 : 537 43
15. Dinney CP, Awad SA, Gajewski JB et al. Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma. Urology 1992 39 : 122 9
16. Mäntylä M, Nordman E, Minkkinen J. Postoperative radiotherapy of renal adenocarcinoma. Ann Clin Res 1977 9 : 252 6
17. Patard JJ, Leray E, Cindolo L et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 2004 172 : 858 62
18. Beisland C, Medby PC, Beisland HO. Renal cell carcinoma: gender difference in incidental detection and cancer-specific survival. Scan J Urol Nephrol 2002 36 : 414 8
19. Vallancien G, Torres LO, Gurfinkel E, Veillon B, Brisset JM. Incidental detection of renal tumors by abdominal ultrasonography. Eur Urol 1990 18 : 94 6
20. Doherty JG, Rüfer A, Bartholomew P, Beaumont DM. The presentation, treatment and outcome of renal cell carcinoma in old age. Age Ageing 1999 28 : 359 62
21. Walther MM, Patel B, Choyke PL et al. Hypercalcemia in patients with metastatic renal cell carcinoma: effect of nephrectomy and metabolic evaluation. J Urol 1997 158 : 733 9
22. Vassilopoulou-Sellin R, Newman BM, Taylor SH, Guinee VF. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer 1993 71 : 1309 12
23. Iversen OH, Roger M, Solberg HE, Wetteland P. Rising erythrocyte sedimentation rate during several years before diagnosis can be a predictive factor in 70 % of renal cell carcinoma patients. The benefit of knowing subject-based reference values. J Intern Med 1996 240 : 133 41
24. El-Saeity NS, Sidhu PS. 'Scrotal varicocele, exclude a renal tumour.' Is this evidence based? Clin Radiol 2006 61 : 593 9
25. Papac RJ, Poo-Hwu WJ. Renal cell carcinoma: a paradigm of lanthanic disease. Am J Clin Oncol 1999 22 : 223 31
26. Walther MM, Johnson B, Culley D et al. Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival. J Urol 1998 159 : 718 22
27. Blay JY, Rossi JF, Wijdenes J et al. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer 1997 72 : 424 30
28. Kirkali Z, Esen AA, Kirkali G, Güner G. Ferritin: a tumor marker expressed by renal cell carcinoma. Eur Urol 1995 28 : 131 4